A concern regarding the potential for DPP-IV inhibitors to affect immune function and increase infection rates has been raised [4,5], although a recently published analysis of safety using pooled source data showed no significant difference in the incidence of overall or specific types of infection [6]. Here, DPP4 is linked to infection.